↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Czech Republic NEN contract award · ocds-ted-468950-2025-2

Czechia – Antineoplastic agents – Léčivé přípravky s obsahem obinutuzumabu a brentuximab vedotinu

Fakultní nemocnice Hradec Králové awarded Kč31.9M to Takeda Pharmaceuticals Czech Republic s.r.o. for Professional Services & Consulting in July 2025 — one of 1,134 awards this buyer has made, above its typical award size.

Professional Services & Consulting
17 Jul 2025
Award date
Kč31.9M
Contract value

Buying agency

Fakultní nemocnice Hradec Králové
1,134 Awards
Kč13.9M Avg award
Above vs typical

Winning supplier

Takeda Pharmaceuticals Czech Republic s.r.o.
131 Awards
29 Buyers
Kč3.2B Total won

Contract description

Czechia – Antineoplastic agents – Léčivé přípravky s obsahem obinutuzumabu a brentuximab vedotinu

Premium

Related awards · Fakultní nemocnice Hradec Králové

1,134 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

1,090 more awards from this buyer · full history & CSV export

Premium

Other wins · Takeda Pharmaceuticals Czech Republic s.r.o.

131 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Fakultní nemocnice Hradec Králové and Takeda Pharmaceuticals Czech Republic s.r.o. — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up